These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Gallo O, Bianchi S, Giannini A, Gallina E, Libonati GA, Fini-Storchi O. Laryngoscope; 1991 May; 101(5):487-93. PubMed ID: 2030628 [Abstract] [Full Text] [Related]
4. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX. Anticancer Res; 2001 May; 21(4B):3021-9. PubMed ID: 11712805 [Abstract] [Full Text] [Related]
5. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Liu MT, Yeh CY. Radiat Med; 1998 May; 16(2):113-7. PubMed ID: 9650898 [Abstract] [Full Text] [Related]
10. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M. J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156 [Abstract] [Full Text] [Related]
11. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system]. Mao YP, Hong MH, Sun Y, Liang SB, Li L, Liu LZ, Tang LL, Cao SM, Lin AH, Lu TX, Liu MZ, Ma J. Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881 [Abstract] [Full Text] [Related]
16. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Kornstein MJ, Brooks JS, Elder DE. Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758 [Abstract] [Full Text] [Related]
17. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. Nicholson JK, McDougal JS, Spira TJ, Cross GD, Jones BM, Reinherz EL. J Clin Invest; 1984 Jan; 73(1):191-201. PubMed ID: 6228564 [Abstract] [Full Text] [Related]
18. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies. Nowak JS, Lanzrein C. Neoplasma; 1984 Jan; 31(3):281-9. PubMed ID: 6610835 [Abstract] [Full Text] [Related]